Amneal Pharmaceuticals
AMRX
AMRX
160 hedge funds and large institutions have $511M invested in Amneal Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 53 increasing their positions, 50 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
5% less call options, than puts
Call options by funds: $1.57M | Put options by funds: $1.66M
1.25% less ownership
Funds ownership: 68.44% → 67.2% (-1.2%)
25% less capital invested
Capital invested by funds: $682M → $511M (-$171M)
Holders
160
Holding in Top 10
1
Calls
$1.57M
Puts
$1.66M
Top Buyers
| 1 | +$4.45M | |
| 2 | +$2.89M | |
| 3 | +$2.39M | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
+$2.31M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.24M |
Top Sellers
| 1 | -$5.67M | |
| 2 | -$4.92M | |
| 3 | -$3.47M | |
| 4 |
Two Sigma Investments
New York
|
-$3.26M |
| 5 |
Renaissance Technologies
New York
|
-$3.02M |